NGVT vs. OLN, ASH, BCPC, HUN, CC, IOSP, HWKN, ECVT, PRM, and SLI
Should you be buying Ingevity stock or one of its competitors? The main competitors of Ingevity include Olin (OLN), Ashland (ASH), Balchem (BCPC), Huntsman (HUN), Chemours (CC), Innospec (IOSP), Hawkins (HWKN), Ecovyst (ECVT), Perimeter Solutions (PRM), and Standard Lithium (SLI). These companies are all part of the "chemicals & allied products" industry.
Ingevity (NYSE:NGVT) and Olin (NYSE:OLN) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment.
Olin received 106 more outperform votes than Ingevity when rated by MarketBeat users. However, 65.39% of users gave Ingevity an outperform vote while only 59.65% of users gave Olin an outperform vote.
In the previous week, Olin had 3 more articles in the media than Ingevity. MarketBeat recorded 3 mentions for Olin and 0 mentions for Ingevity. Ingevity's average media sentiment score of 1.76 beat Olin's score of 1.12 indicating that Ingevity is being referred to more favorably in the media.
91.6% of Ingevity shares are held by institutional investors. Comparatively, 88.7% of Olin shares are held by institutional investors. 1.1% of Ingevity shares are held by company insiders. Comparatively, 1.6% of Olin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Ingevity has a beta of 1.79, meaning that its stock price is 79% more volatile than the S&P 500. Comparatively, Olin has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.
Ingevity currently has a consensus target price of $55.00, suggesting a potential upside of 12.59%. Olin has a consensus target price of $60.00, suggesting a potential upside of 11.61%. Given Ingevity's stronger consensus rating and higher possible upside, equities research analysts clearly believe Ingevity is more favorable than Olin.
Olin has a net margin of 5.32% compared to Ingevity's net margin of -6.84%. Ingevity's return on equity of 18.65% beat Olin's return on equity.
Olin has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks.
Summary
Ingevity and Olin tied by winning 9 of the 18 factors compared between the two stocks.
Get Ingevity News Delivered to You Automatically
Sign up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NGVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ingevity Competitors List
Related Companies and Tools
